These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11127940)

  • 1. Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5.
    Kestell P; Pruijn FB; Siim BG; Palmer BD; Wilson WR
    Cancer Chemother Pharmacol; 2000; 46(5):365-74. PubMed ID: 11127940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.
    Helsby NA; Wheeler SJ; Pruijn FB; Palmer BD; Yang S; Denny WA; Wilson WR
    Chem Res Toxicol; 2003 Apr; 16(4):469-78. PubMed ID: 12703963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; van Zijl P; Denny WA; Wilson WR
    J Med Chem; 1995 Mar; 38(7):1229-41. PubMed ID: 7707325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.
    Helsby NA; Ferry DM; Patterson AV; Pullen SM; Wilson WR
    Br J Cancer; 2004 Mar; 90(5):1084-92. PubMed ID: 14997211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.
    Anlezark GM; Melton RG; Sherwood RF; Wilson WR; Denny WA; Palmer BD; Knox RJ; Friedlos F; Williams A
    Biochem Pharmacol; 1995 Aug; 50(5):609-18. PubMed ID: 7669063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E; Parkinson GN; Denny WA; Neidle S
    J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.
    Palmer BD; Wilson WR; Cliffe S; Denny WA
    J Med Chem; 1992 Aug; 35(17):3214-22. PubMed ID: 1507207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Atwell GJ; Schultz D; Xu XZ; Denny WA
    J Med Chem; 1994 Jul; 37(14):2175-84. PubMed ID: 8035424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mustard group structure on pathways of in vitro metabolism of anticancer N-(2-hydroxyethyl)-3,5-dinitrobenzamide 2-mustard prodrugs.
    Helsby NA; Goldthorpe MA; Tang MH; Atwell GJ; Smith EM; Wilson WR; Tingle MD
    Drug Metab Dispos; 2008 Feb; 36(2):353-60. PubMed ID: 17998296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killing.
    Wilson WR; Pruijn FB
    Clin Exp Pharmacol Physiol; 1995 Nov; 22(11):881-5. PubMed ID: 8593750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans.
    Gu Y; Atwell GJ; Wilson WR
    Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards.
    Wilson WR; Hicks KO; Pullen SM; Ferry DM; Helsby NA; Patterson AV
    Radiat Res; 2007 Jun; 167(6):625-36. PubMed ID: 17523848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, distribution, and metabolism of the novel bioreductive alkylating indoloquinone EO9 in rodents.
    Workman P; Binger M; Kooistra KL
    Int J Radiat Oncol Biol Phys; 1992; 22(4):713-6. PubMed ID: 1544843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs.
    Blakey DC; Davies DH; Dowell RI; East SJ; Burke PJ; Sharma SK; Springer CJ; Mauger AB; Melton RG
    Br J Cancer; 1995 Nov; 72(5):1083-8. PubMed ID: 7577451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB.
    Gungor T; Yetis G; Onder FC; Tokay E; Tok TT; Celik A; Ay M; Kockar F
    Med Chem; 2018; 14(5):495-507. PubMed ID: 29189173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro reduction as an electronic switch for bioreductive drug activation.
    Siim BG; Denny WA; Wilson WR
    Oncol Res; 1997; 9(6-7):357-69. PubMed ID: 9406242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines.
    Palmer BD; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 1990 Jan; 33(1):112-21. PubMed ID: 2296009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
    Tang MH; Helsby NA; Wilson WR; Tingle MD
    Toxicology; 2005 Dec; 216(2-3):129-39. PubMed ID: 16129536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
    Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
    J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.